Rabeprazole Related Compound E

CAS No. 117977-21-6

Rabeprazole Related Compound E( Rabeprazole thioether | Rabeprazole impurity E )

Catalog No. M10610 CAS No. 117977-21-6

Rabeprazole is an antiulcer drug in the class of proton pump inhibitors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
200MG 27 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Rabeprazole Related Compound E
  • Note
    Research use only, not for human use.
  • Brief Description
    Rabeprazole is an antiulcer drug in the class of proton pump inhibitors.
  • Description
    Rabeprazole is an antiulcer drug in the class of proton pump inhibitors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Rabeprazole thioether | Rabeprazole impurity E
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Proton Pump
  • Recptor
    Proton pump
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    117977-21-6
  • Formula Weight
    343.44
  • Molecular Formula
    C18H21N3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    Limited solubility
  • SMILES
    COCCCOC1=C(C)C(CSC2=NC3=CC=CC=C3N2)=NC=C1
  • Chemical Name
    2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ohara T, et al. Helicobacter. 2001 Jun;6(2):125-9.
molnova catalog
related products
  • Tegoprazan

    A novel potent, highly selective, competitive and orally active inhibitor of gastric H+/K+-ATPase with IC50 of ranging 0.29-0.52 uM porcine, canine and human H+/K+-ATPases in vitro.

  • TAK-438

    A novel potent, potassium-competitive acid blocker (P-CAB) that inhibits H(+),K(+)-ATPase activity in porcine gastric microsomes with IC50 of 19 nM at pH 6.5.

  • Revaprazan hydrochlo...

    Revaprazan (SB-641257;YH-1885) potent potassium-competitive acid blocker (P-CAB) that inhibits H+,K+-ATPase in a reversible and K+-competitive manner.